Novo Nordisk and Eli Lilly dominate the market for GLP-1 drugs, and are racing ahead to produce more of them. More
Articles
3 EV Charging Stocks to Buy on the Dip: June 2024
It’s time to revisit some of the top EV charging stocks to buy on the dip – especially with EV sales starting to accelerate again. More
3 Fintech Stocks to Buy if You Are Looking to Build Wealth
Discover top fintech stocks to buy that are set to soar with the sector's expansion and technological advancements. More
7 Reasons to Make Options Trading Part of Your Portfolio
Looking to revitalize your portfolio and maximize potential profits? Options trading can help you do it. Here’s why you should consider investing in options. More
The Hype Heist: How 3 Overvalued Stocks Are Robbing Investors Blind
These three overvalued stocks highlight the pitfalls of ignoring fundamental investing principles in a bullish market. More
Smaller Family Units, Bigger Profits: 3 Top Real Estate Stocks to Buy in 2024
These real estate stocks are poised to capitalize on rising demand for rental housing driven by smaller family units and migration trends. More
3 Stocks to Buy Before This OpenAI Project Shocks Wall Street
These are the three stocks to buy across various sectors that could benefit from OpenAI's Sora text-to-video AI system. More
